ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

RZLT Rezolute Inc

3.31
0.34 (11.45%)
2024年5月4日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Rezolute Inc RZLT NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.34 11.45% 3.31 07:53:39
始値 安値 高値 終値 前日終値
3.06 2.98 3.38 3.31 2.97
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/2321:00GLOBEPhase 2 RIZE Study Sub-Analyses to be Presented at the 2024..
2024/3/1206:03EDGAR2Form 8-K - Current report
2024/3/1123:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0621:30GLOBERezolute Reports Validation of the Potential Use of RZ358..
2024/2/2722:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2307:00EDGAR2Form 8-K - Current report
2024/2/2201:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1407:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1406:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/2/1406:10EDGAR2Form 8-K - Current report
2024/2/1406:05GLOBERezolute Reports Second Quarter Fiscal 2024 Results and..
2024/1/3007:15EDGAR2Form 8-K - Current report
2024/1/2602:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2602:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2602:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2602:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2422:00GLOBERezolute Expands Leadership Team with Appointment of Daron..
2024/1/2322:00GLOBERezolute Receives Innovation Passport Designation from the..
2023/12/1506:01EDGAR2Form 8-K - Current report
2023/12/1422:00GLOBERezolute Initiates Phase 3 Clinical Study for RZ358 in..
2023/12/1322:00GLOBERezolute Completes Enrollment of its Phase 2 Study in..
2023/11/3014:15EDGAR2Form EFFECT - Notice of Effectiveness
2023/11/2307:16EDGAR2Form S-3/A - Registration statement under Securities Act of..
2023/11/2306:35EDGAR2Form 8-K - Current report
2023/11/1722:00GLOBERezolute to Participate in BTIG’s 3rd Annual Ophthalmology..
2023/11/1523:08EDGAR2Form S-3 - Registration statement under Securities Act of..
2023/11/1406:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/1406:13EDGAR2Form 8-K - Current report
2023/11/1406:05GLOBERezolute Reports First Quarter Fiscal 2024 Results
2023/10/1905:30EDGAR2Form 8-K - Current report
2023/10/1721:00GLOBERezolute Receives Priority Medicines (PRIME) Eligibility..
2023/10/1405:47EDGAR2Form 8-K - Current report
2023/10/1405:30EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2023/10/1121:00GLOBERezolute Announces Further Evidence of RZ358’s Efficacy in..
2023/9/1505:22EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2023/9/1505:10EDGAR2Form 8-K - Current report
2023/9/1505:05GLOBERezolute Reports Full Year Fiscal 2023 Results and..
2023/9/0620:00GLOBERezolute to Participate in Upcoming Investor Conferences in..
2023/7/0700:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/6/2805:05GLOBERezolute to Initiate a Pivotal Phase 3 Study of RZ358 in..
2023/5/1205:05GLOBERezolute Reports Third Quarter Fiscal 2023 Results and..

最近閲覧した銘柄

Delayed Upgrade Clock